L-valine (Val)

L-valine is an essential branched-chain amino acid (BCAA) that must be acquired through dietary intake, as the human body lacks the metabolic pathways to synthesize it de novo (PubChem, CID 6287). It plays a vital role in biological processes including protein biosynthesis, muscle tissue regeneration, and energy metabolism via its conversion into succinyl-CoA for the citric acid cycle (NIH StatPearls, "Biochemistry, Essential Amino Acids"). While L-valine is a metabolite rather than a traditional drug target like a receptor or enzyme, its physiological homeostasis is critical for health; for example, the genetic substitution of valine for glutamic acid in hemoglobin is the molecular cause of sickle cell anemia (PubMed, PMID 10323825). Clinical applications involve using L-valine in parenteral nutrition and supplements to manage hepatic encephalopathy and support recovery in catabolic states (PubMed, PMID 27175371). However, impaired metabolism of L-valine is a hallmark of Maple Syrup Urine Disease (MSUD), a condition requiring strict dietary management and therapeutic interventions to prevent neurotoxic accumulation (NIH GARD). Recent research also suggests that elevated valine levels are linked to the development of insulin resistance and serve as a necessary nutrient for the growth of certain T-cell acute lymphoblastic leukemias (Nature, PMID 31534224).

Other names

(2S)-2-amino-3-methylbutanoic acid(S)-alpha-Aminoisovaleric acid2-Amino-3-methylbutyric acidValine

As an essential amino acid, L-valine acts as a structural building block for protein synthesis and an oxidative substrate for the tricarboxylic acid (TCA) cycle (NIH StatPearls). In therapeutic management of metabolic disorders, drugs like sodium phenylbutyrate interact with the branched-chain amino acid metabolic pathway to reduce the accumulation of valine and its toxic ketoacid derivatives (PubMed, PMID 21333924).